• 1. 367. Thiazoles derived from chrysean and isoChrysean
  A. Adams,R. Slack J. Chem. Soc. 1956 1870
• 2. 437. Congeners of pyridine-4-carboxyhydrazide. Part I. Derivatives of 4-cyanopyridine and 2-cyanothiazole
  D. D. Libman,R. Slack J. Chem. Soc. 1956 2253
• 3. Recyclisation of carbo- and heterocyclic compounds involving malononitrile and its derivatives
  Victor P. Litvinov Russ. Chem. Rev. 1999 68 39
• 4. Thiazolopyridinium salts. Part I. Synthesis of some thiazolo[3,2-a]-pyridinium salts
  Gurnos Jones,D. G. Jones J. Chem. Soc. C 1967 515
• 5. Imidazoquinolinethiones from 8-aminoquinolines by a novel peri-participation
  Thierry Besson,Charles W. Rees,David G. Roe,Valérie Thiéry J. Chem. Soc. Perkin Trans. 1 2000 555

Professional Introduction to 1,3-thiazole-2-carbonitrile (CAS No. 1452-16-0)

1,3-thiazole-2-carbonitrile, with the chemical formula C?H?N?S and CAS number 1452-16-0, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the thiazole class, characterized by a sulfur-containing five-membered ring fused with a pyridine-like structure. The presence of a nitrile group at the 2-position introduces unique reactivity and functional properties, making it a valuable scaffold for drug discovery and synthetic chemistry.

The structural motif of 1,3-thiazole-2-carbonitrile is highly versatile, allowing for diverse modifications that can fine-tune its biological activity. The thiazole core is a well-documented pharmacophore in medicinal chemistry, with numerous derivatives exhibiting antimicrobial, anti-inflammatory, and anticancer properties. The nitrile group further enhances its potential as a bioactive molecule by serving as a site for further functionalization via hydrolysis or reduction reactions.

In recent years, 1,3-thiazole-2-carbonitrile has been extensively studied for its role in developing novel therapeutic agents. One of the most compelling areas of research involves its application in anticancer drug design. Studies have demonstrated that derivatives of this compound can interact with key biological targets involved in cell proliferation and apoptosis. For instance, modifications at the 4- or 5-position of the thiazole ring have been shown to modulate the activity of enzymes such as tyrosine kinases, which are often overexpressed in cancer cells.

Moreover, the nitrile group in 1,3-thiazole-2-carbonitrile serves as an excellent handle for further chemical transformations. Researchers have leveraged this functionality to synthesize a series of analogs that exhibit enhanced binding affinity to protein targets. Notably, some derivatives have shown promising results in preclinical studies against chronic myeloid leukemia (CML) and other hematological malignancies. The ability to fine-tune the electronic properties of the nitrile group through substituent effects has allowed chemists to optimize potency and selectivity.

Another emerging area of interest is the use of 1,3-thiazole-2-carbonitrile in antimicrobial applications. The thiazole scaffold is known to disrupt bacterial cell wall synthesis and inhibit essential metabolic pathways. Recent publications highlight its derivatives as effective inhibitors against multidrug-resistant strains of Gram-negative bacteria. The nitrile moiety plays a crucial role in these interactions by engaging in hydrogen bonding or π-stacking interactions with bacterial proteins.

The synthesis of 1,3-thiazole-2-carbonitrile typically involves multi-step organic reactions starting from readily available precursors such as thioamides or thioureas. A common synthetic route includes cyclization followed by cyanation to introduce the nitrile group at the 2-position. Advances in catalytic methods have enabled more efficient and scalable production processes, making this compound more accessible for industrial applications.

In addition to its pharmaceutical relevance, 1,3-thiazole-2-carbonitrile has found utility in materials science and agrochemical research. Its heterocyclic structure contributes to unique electronic and optical properties, making it a candidate for organic semiconductors or luminescent materials. Furthermore, certain derivatives have shown herbicidal activity by interfering with plant growth regulators.

The growing body of research on 1,3-thiazole-2-carbonitrile underscores its importance as a versatile building block in synthetic chemistry. Ongoing studies aim to expand its pharmacological profile by exploring novel derivatives and reaction pathways. Collaborative efforts between academia and industry are expected to accelerate the development of next-generation therapeutics based on this scaffold.

As our understanding of molecular interactions continues to evolve, compounds like 1,3-thiazole-2-carbonitrile (CAS No. 1452-16-0) will remain at the forefront of innovation in drug discovery. Their unique structural features offer unparalleled opportunities for designing molecules with tailored biological activities, addressing unmet medical needs across various therapeutic domains.

• 52006-64-1(Thiazole, methyl-)
• 3581-87-1(2-Methylthiazole)
• 100516-71-0(5-methyl-1,3-thiazole-2-carbonitrile)
• 100516-98-1(4-methyl-1,3-thiazole-2-carbonitrile)
• 260998-77-4(Thiazole, 2-methyl-,radical ion(1+) (9CI))
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)